Persistent lipid changes with long-term treatment with mipomersen
Dr. Paul Barton Duell (Oregon Health and Science University, Portland, OR, USA)
Recorded at ISA2015, Amsterdam, The Netherlands on May 24-26, 2015
ISA2015 | Clinical Breakthroughs Dr. Barton Duell presented efficacy and safety data of 4.5 years of treatment with mipomersen, showing sustained lowering of LDL-c, Lp(a) and apoB, without revealing new safety concerns.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.